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Risk Stratification tool

Background

ADD-RS is a set of 12 clinical markers of aortic dissection released in 2010 by
American Heart Association (AHA) and the American College of Cardiology
(ACC) (5). This scoring system was developed using the International Registry
for Aortic Dissection, comparing common historical and clinical features. The
strength of the ADD-RS scoring system is that its retrospective analysis of IRAD
showed that low risk scores of 0 had a sensitivity for AD of 95.4%. Of the 4.6%
that had AD with a score of 0, 48.6% of these patients had abnormal chest
radiographs, including things such as widened mediastinum. If considering that
these patients would be worked up anyway due to an abnormal chest
radiograph, the miss rate of the ADD-RS would be 2.23%.
The ADvISED Trial (Nazerian et al, 2018) evaluated the ADD-RS combined with
D-dimer testing by conducting a multicenter, prospective observational study
which enrolled 1,850 consecutive chest pain patients, 241 (13%) of which were
diagnosed with acute aortic syndrome (AAS). ADD-RS<=1 and negative D-dimer
showed a sensitivity of 98.8%, NPV 99.7%, and LR-0.02. An ADD-RS=0 had a
sensitivity of 99.6%. Furthermore, application of this rule could potentially
spare ~3 in 5 conclusive imaging exams in all patients with AAS, and could avoid
up to 1 in 2 CTA exams in pts with suspected AAS (1).

Aortic dissection (AD) is part of a group of acute aortic syndromes
consisting of intramural aortic hematoma, penetrating aortic ulcer,
and aortic rupture. On its own, the incidence is ~3 to 8 cases per
100,000 per year, and up to 25% of cases are missed. The inhospital mortality when treated is 27%, and with a 2% increase in
mortality/hour. Imaging modalities like CT angiography, TEE, and
MRA have made improved diagnosis of the disease, but are costly,
potentially harmful, time consuming, and require patient stability
when in use (1). The key question we have as emergency
department providers is if there is a way to risk stratify patients for
AD and if so, is there a test with high enough sensitivity and
negative likelihood ratio (-LR) to rule out aortic dissection. Smooth
muscle myosin heavy chain is a proposed modality, which is
released from injured aortic media at the start of AD but there is a
lack of observational studies testing its efficacy as biomarker in
making the diagnosis (2). Hence, algorithms to aid physician in
reducing both misdiagnosis and overtesting is much needed.

Literature Review
Plasma D-dimer, a degradation product of cross linked fibrin by
the endogenous fibrinolytic system, is found to be elevated in
states like cancer, MI, pregnancy, sepsis, or disorders where there
is indiscriminant activation of the coagulation cascade(2). Metaanalysis reviews of D-dimer studies have shown that a cut off level
0.50 ug/mL has proven to have high sensitivity, (-)LR, and negative
predictive value (2)( 3). According to the IRAD-Bio study, when
utilized in the first 24 hours of symptoms, D-dimer has proven to
reliably rule out pulmonary embolism (PE) and acute aortic
dissection with sensitivity of 96.6% and specificity of 46.6%
studied on AD patients(3, 4). Although a rapid, economical, and
accessible biomarker, it is also nonspecific with a low specificity
and PPV, and a poor (+) LR (2). The possibility of excessive
advanced imaging is increased when used alone on a low risk
patient population. Therefore, when coupled with a decision rule
like the Aortic Dissection Detection Risk Score (ADD-RS), it can
provide better utility with increased sensitivity.
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